Building on this distinction, we also found mutations in TP53 and ATRX to be associated specifically with IDHmut-non-codel subtype gliomas (Brat et al., 2015; Cheung et al., 2012) (Figures 2A and 2C). Here, TP53 is linked to central nervous system cancer.